In his weekly clinical update, Dr. Griffin discusses the effectiveness of maternal mRNA COVID-19 vaccination during pregnancy against COVID-19–associated hospitalizations in infants aged <6 months during SARS-CoV-2 Omicron predominance, COVID-19 vaccination recommendations and practices for women of reproductive age by health care providers, molnupiravir for intra-household prevention of COVID-19, delayed peak SARS-CoV-2 viral loads relative to symptom onset and implications for COVID-19 testing programs, viral kinetics of sequential SARS-CoV-2 infections, FDA authorizes updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variants, antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19, long-term cardiovascular, cerebrovascular, and other thrombotic complications in COVID-19 survivors, SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels, and the efficacy of gabapentin For post-COVID-19 olfactory dysfunction.
Click arrow to play
Download TWiV 1050 (32 MB .mp3, 45 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Effectiveness of maternal mRNA COVID-19 vaccination during pregnancy against COVID-19–associated hospitalizations in infants (CDC) 6:09
- COVID-19 vaccination recommendations and practices for women of reproductive age (CDC) 9:26
- Molnupiravir for intra-household prevention of COVID-19 (JOI) 11:28
- Delayed peak SARS-CoV-2 viral loads relative to symptom onset and implications for COVID-19 testing programs 14:46
- Viral kinetics of sequential SARS-CoV-2 infections (Nature) 21:45
- FDA authorizes updated Novavax COVID-19 vaccine (FDA) 23:22
- Antiviral efficacy of molnupiravir vs ritonavir/nirmatrelvir in patients with COVID-19 (The Lancet) 24:53
- Long-term cardiovascular, cerebrovascular, and other thrombotic complications in COVID-19 survivors (CID) 40:06
- SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in coronary vessels (NCR) 42:36
- Efficacy of gabapentin For Post–COVID-19 47:15
- Contribute to our Floating Doctors fundraiser at PWB 47:56
- Letters read on TWiV 1050 48:24
- Dr. Griffin’s COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
Leave a Reply